by Alison Bass | May 28, 2009 | Uncategorized
In order to truly stabilize the economy and rescue Medicare from financial collapse, the Obama administration knows it has to do something about the elephant in the room: ever-rising health care costs. In this week’s New Yorker, surgeon-writer Atul Gawande...
by Alison Bass | May 20, 2009 | Uncategorized
On his Pharma Marketing blog today, John Mack recaps the controversy over the patient who was paid hundreds of thousands of dollars by Bristol Myers Squibb to promote Abilify and then changed his tune. (Andy Behrman, aka “Electroboy,” began talking out...
by Alison Bass | May 14, 2009 | Uncategorized
I had the pleasure of speaking to a large group of senior citizens yesterday at a Jewish community center in the Boston area. I had been invited there to talk about Side Effects, and while the focus of my talk (like my book) was how drug companies deceived the...
by Alison Bass | May 7, 2009 | Uncategorized
As The Boston Globe’s unions vote on whether to bow to the inevitable and make the financial concessions demanded to keep their newspaper alive, it seems a sad but apropos time to bring attention to a new survey on the declining state of health care journalism....
by Alison Bass | Apr 30, 2009 | Uncategorized
For years, many scientists and doctors have argued that it was not necessary to police conflicts of interest and other irregularities in scientific research, Money, they argued, couldn’t possibly taint their scientific judgment. And even if it did, science was...
by Alison Bass | Apr 20, 2009 | Uncategorized
Anyone keeping up with the news knows that a number of prominent psychiatrists have been under seige of late after Congressional allegations that they failed to disclose lucrative payments from drug companies whose products they were studying and promoting on the...
